Skip to main content
NCBI home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1995 Jun;115(4):629–635. doi: 10.1111/j.1476-5381.1995.tb14978.x

Polydeoxyribonucleotides and nitric oxide release from guinea-pig hearts during ischaemia and reperfusion.

E Masini 1, M Lupini 1, L Mugnai 1, S Raspanti 1, P F Mannaioni 1
PMCID: PMC1908494  PMID: 7582482

Abstract

1. Two polydeoxyribonucleotides, produced by the controlled hydrolysis of DNA of mammalian lung (defibrotide and its lower molecular weight fraction, P.O. 085 DV), were studied for their ability to modify the release of nitrite and the coronary flow in perfusates collected from isolated, normally perfused hearts of guinea-pigs and from hearts subjected to regional ischaemia and reperfusion. 2. In guinea-pig normally perfused hearts, both defibrotide (DFT) and its fraction, P.O. 085 DV, increase the amount of nitrite appearing in perfusates in a concentration-dependent fashion. At the highest concentration studied (10(-6) M), P.O. 085 DV was more effective than DFT. A concomitant increase in the coronary flow was observed. 3. The increase in nitrite in perfusates and the increase in coronary flow induced by both DFT and P.O. 085 DV were significantly reduced by NG-monomethyl-L-arginine (L-NMMA, 10(-4) M), an inhibitor of nitric oxide synthase (NOS). 4. The endothelium-dependent vasodilator, acetylcholine (ACh), enhances the formation of nitrite and the coronary flow. Both the increase in coronary flow and in the formation of nitrite were significantly reduced by L-NMMA (10(-4) M). 5. In guinea-pig hearts subjected to ischaemia and reperfusion, the effect of both compounds in increasing the amount of nitrite in perfusates was more evident and more pronounced with P.O. 085 DV. 6. Reperfusion-induced arrhythmias were significantly reduced by both compounds to the extent of complete protection afforded by compound P.O. 085 DV. 7. The cardioprotective and antiarrhythmic effects of DFT and P.O. 085 DV are discussed.

Full text

PDF
629

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Beckman J. S., Beckman T. W., Chen J., Marshall P. A., Freeman B. A. Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide. Proc Natl Acad Sci U S A. 1990 Feb;87(4):1620–1624. doi: 10.1073/pnas.87.4.1620. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Berti F., Rossini G., Omini C., Daffonchio L., Tondo C., Cali G. Defibrotide protects rabbit myocardium from ischemia: relationship with the eicosanoid system. Pol J Pharmacol Pharm. 1987 Sep-Oct;39(5):657–665. [PubMed] [Google Scholar]
  3. Berti F., Rossoni G., Bianchi G., Alberico P., Tettamanti R., Calvani A. B., Mantovani M., Prino G. Effects of defibrotide on prostacyclin release from isolated rabbit kidneys and protection from post-ischemic acute renal failure in vivo. Eicosanoids. 1991;4(4):209–215. [PubMed] [Google Scholar]
  4. Berti F., Rossoni G., Galli G., Magni F., Mantovani M., Calvani A. B., Porta R., Prino G. Defibrotide has antiischemic activity in perfused rabbit hearts, preventing tissue Ca++ overloading. Thromb Res. 1992 Jan 1;65(1):13–26. doi: 10.1016/0049-3848(92)90221-u. [DOI] [PubMed] [Google Scholar]
  5. Bianchi G., Barone D., Lanzarotti E., Tettamanti R., Porta R., Moltrasio D., Cedro A., Salvetti L., Mantovani M., Prino G. Defibrotide, a single-stranded polydeoxyribonucleotide acting as an adenosine receptor agonist. Eur J Pharmacol. 1993 Jul 20;238(2-3):327–334. doi: 10.1016/0014-2999(93)90864-e. [DOI] [PubMed] [Google Scholar]
  6. Bianchi G., Calvani A. B., Mantovani M., Prino G. Enhancement by defibrotide of prostanoid neosynthesis from arachidonic acid: an adenosine receptor-mediated effect? Semin Thromb Hemost. 1991 Oct;17(4):399–403. doi: 10.1055/s-2007-1002643. [DOI] [PubMed] [Google Scholar]
  7. Botting R., Vane J. R. Vasoactive mediators derived from the endothelium. Arch Mal Coeur Vaiss. 1989 Nov;82(SPEC):11–14. [PubMed] [Google Scholar]
  8. Buxton I. L., Cheek D. J., Eckman D., Westfall D. P., Sanders K. M., Keef K. D. NG-nitro L-arginine methyl ester and other alkyl esters of arginine are muscarinic receptor antagonists. Circ Res. 1993 Feb;72(2):387–395. doi: 10.1161/01.res.72.2.387. [DOI] [PubMed] [Google Scholar]
  9. Dieterich H. A., Löffelholz K. Effect of coronary perfusion rate on the hydrolysis of exogenous and endogenous acetylcholine in the isolated heart. Naunyn Schmiedebergs Arch Pharmacol. 1977 Jan;296(2):143–148. doi: 10.1007/BF00508466. [DOI] [PubMed] [Google Scholar]
  10. Gelvan D., Saltman P., Powell S. R. Cardiac reperfusion damage prevented by a nitroxide free radical. Proc Natl Acad Sci U S A. 1991 Jun 1;88(11):4680–4684. doi: 10.1073/pnas.88.11.4680. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Gryglewski R. J., Marcinkiewicz E., Radomski M., Swies J. Prostacyclin and the mechanism of action of defibrotide. Eicosanoids. 1989;2(3):163–167. [PubMed] [Google Scholar]
  12. Hearse D. J., Garlick P. B., Humphrey S. M. Ischemic contracture of the myocardium: mechanisms and prevention. Am J Cardiol. 1977 Jun;39(7):986–993. doi: 10.1016/s0002-9149(77)80212-9. [DOI] [PubMed] [Google Scholar]
  13. Hohlfeld T., Strobach H., Schrör K. Stimulation of endogenous prostacyclin protects the reperfused pig myocardium from ischemic injury. J Pharmacol Exp Ther. 1993 Jan;264(1):397–405. [PubMed] [Google Scholar]
  14. Kaul N., Siveski-Iliskovic N., Hill M., Slezak J., Singal P. K. Free radicals and the heart. J Pharmacol Toxicol Methods. 1993 Oct;30(2):55–67. doi: 10.1016/1056-8719(93)90008-3. [DOI] [PubMed] [Google Scholar]
  15. Lefer A. M., Ogletree M. L., Smith J. B., Silver M. J., Nicolaou K. C., Barnette W. E., Gasic G. P. Prostacyclin: a potentially valuable agent for preserving myocardial tissue in acute myocardial ischemia. Science. 1978 Apr 7;200(4337):52–54. doi: 10.1126/science.345441. [DOI] [PubMed] [Google Scholar]
  16. Lorenz W., Doenicke A. Histamine release in clinical conditions. Mt Sinai J Med. 1978 May-Jun;45(3):357–386. [PubMed] [Google Scholar]
  17. Mannaioni P. F., Masini E. The release of histamine by free radicals. Free Radic Biol Med. 1988;5(3):177–197. doi: 10.1016/0891-5849(88)90080-9. [DOI] [PubMed] [Google Scholar]
  18. Masini E., Di Bello M. G., Pistelli A., Raspanti S., Gambassi F., Mugnai L., Lupini M., Mannaioni P. F. Generation of nitric oxide from nitrovasodilators modulates the release of histamine from mast cells. J Physiol Pharmacol. 1994 Mar;45(1):41–53. [PubMed] [Google Scholar]
  19. Morikawa E., Huang Z., Moskowitz M. A. L-arginine decreases infarct size caused by middle cerebral arterial occlusion in SHR. Am J Physiol. 1992 Nov;263(5 Pt 2):H1632–H1635. doi: 10.1152/ajpheart.1992.263.5.H1632. [DOI] [PubMed] [Google Scholar]
  20. Palmer R. M., Ferrige A. G., Moncada S. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature. 1987 Jun 11;327(6122):524–526. doi: 10.1038/327524a0. [DOI] [PubMed] [Google Scholar]
  21. Salvemini D., Mollace V., Pistelli A., Anggard E., Vane J. Metabolism of glyceryl trinitrate to nitric oxide by endothelial cells and smooth muscle cells and its induction by Escherichia coli lipopolysaccharide. Proc Natl Acad Sci U S A. 1992 Feb 1;89(3):982–986. doi: 10.1073/pnas.89.3.982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Sato S., Tominaga T., Ohnishi T., Ohnishi S. T. EPR spin-trapping study of nitric oxide formation during bilateral carotid occlusion in the rat. Biochim Biophys Acta. 1993 Apr 30;1181(2):195–197. doi: 10.1016/0925-4439(93)90111-d. [DOI] [PubMed] [Google Scholar]
  23. Schrör K., Ackermann G., Hohlfeld T., Löbel P., Ney P., Schröder H., Strobach H. Endothelial protection by defibrotide--a new strategy for treatment of myocardial infarction? Z Kardiol. 1989;78 (Suppl 6):35–41. [PubMed] [Google Scholar]
  24. Schrör K., Köhler P., Müller M., Peskar B. A., Rösen P. Prostacyclin-thromboxane interactions in the platelet-perfused in vitro heart. Am J Physiol. 1981 Jul;241(1):H18–H25. doi: 10.1152/ajpheart.1981.241.1.H18. [DOI] [PubMed] [Google Scholar]
  25. Siegfried M. R., Erhardt J., Rider T., Ma X. L., Lefer A. M. Cardioprotection and attenuation of endothelial dysfunction by organic nitric oxide donors in myocardial ischemia-reperfusion. J Pharmacol Exp Ther. 1992 Feb;260(2):668–675. [PubMed] [Google Scholar]
  26. Simpson P. J., Mitsos S. E., Ventura A., Gallagher K. P., Fantone J. C., Abrams G. D., Schork M. A., Lucchesi B. R. Prostacyclin protects ischemic reperfused myocardium in the dog by inhibition of neutrophil activation. Am Heart J. 1987 Jan;113(1):129–137. doi: 10.1016/0002-8703(87)90020-2. [DOI] [PubMed] [Google Scholar]
  27. Thiemermann C., Löbel P., Schrör K. Usefulness of defibrotide in protecting ischemic myocardium from early reperfusion damage. Am J Cardiol. 1985 Dec 1;56(15):978–982. doi: 10.1016/0002-9149(85)90416-3. [DOI] [PubMed] [Google Scholar]
  28. Thiemermann C., Thomas G. R., Vane J. R. Defibrotide reduces infarct size in a rabbit model of experimental myocardial ischaemia and reperfusion. Br J Pharmacol. 1989 Jun;97(2):401–408. doi: 10.1111/j.1476-5381.1989.tb11967.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Thiemermann C., Thomas G. R., Vane J. R. Effects of defibrotide on infarct size and regional myocardial blood flow on the ischaemic reperfused rabbit heart. Prog Clin Biol Res. 1989;301:131–135. [PubMed] [Google Scholar]
  30. Ulutin O. N., Balkuv-Ulutin S., Ugur M. S., Ulutin T., Ozsoy Y., Cizmeci G. The pharmacology and clinical pharmacology of defibrotide: a new profibrinolytic, antithrombotic and anti-platelet substance. Adv Exp Med Biol. 1990;281:429–438. doi: 10.1007/978-1-4615-3806-6_46. [DOI] [PubMed] [Google Scholar]
  31. Wink D. A., Hanbauer I., Krishna M. C., DeGraff W., Gamson J., Mitchell J. B. Nitric oxide protects against cellular damage and cytotoxicity from reactive oxygen species. Proc Natl Acad Sci U S A. 1993 Nov 1;90(21):9813–9817. doi: 10.1073/pnas.90.21.9813. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Wolff A. A., Levi R. Histamine and cardiac arrhythmias. Circ Res. 1986 Jan;58(1):1–16. doi: 10.1161/01.res.58.1.1. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES